- Home
- PZZA vs MDXG Comparison
PZZA vs MDXG Comparison
Compare PZZA & MDXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PZZA | MDXG |
|---|---|---|
| Founded | 1984 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Restaurants | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.0B |
| IPO Year | 1993 | N/A |
Fundamental Metrics
Financial Performance| Metric | PZZA | MDXG |
|---|---|---|
| Price | $35.18 | $5.09 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 8 | 3 |
| Target Price | ★ $48.13 | $10.67 |
| AVG Volume (30 Days) | 956.2K | ★ 1.0M |
| Earning Date | 02-26-2026 | 02-25-2026 |
| Dividend Yield | ★ 5.13% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.14 | 0.27 |
| Revenue | ★ $2,086,399,000.00 | $393,442,000.00 |
| Revenue This Year | $2.60 | $19.13 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $31.53 | ★ $19.03 |
| Revenue Growth | N/A | ★ 14.77 |
| 52 Week Low | $30.16 | $5.05 |
| 52 Week High | $55.74 | $9.30 |
Technical Indicators
Market Signals| Indicator | PZZA | MDXG |
|---|---|---|
| Relative Strength Index (RSI) | 33.07 | 22.02 |
| Support Level | $35.50 | $5.05 |
| Resistance Level | $37.24 | $5.41 |
| Average True Range (ATR) | 1.51 | 0.19 |
| MACD | -0.09 | -0.03 |
| Stochastic Oscillator | 10.42 | 5.80 |
Price Performance
Historical ComparisonAbout PZZA Papa John's International Inc.
Papa John's is one of the largest players in the global QSR, or quick-service restaurant, pizza market, boasting more than 6,000 restaurants across nearly 50 countries at the end of 2024. The firm operates a predominantly franchised system, owning 9% of its restaurants and generating revenue from franchise royalties, sales of pizza and related products at its company-owned stores, and sales from its commissary supply chain. The firm is the fourth-largest limited-service pizza chain globally and third in the US (Euromonitor International), with a sizable presence in the UK, China, South Korea, and Chile.
About MDXG MiMedx Group Inc
MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, it sells allografts for ophthalmic surgery and dental applications through licenses to third parties.